money received from the IPO after deducting the actual expenses 4. Acquisition of all ordinary shares of Modern Pharma Company Limited, "Modern Company", which is a transaction concerning asset
involved in the transaction to acquire the land in order to construct and to launch the New project of Wattanapat Samui Hospital In this regards, it is entering into the asset acquisition in accordance with
%) Adjusted Net Profit (loss) for the period (148.9) (8.5%) (945.7) (82.1%) (796.8) (535.0%) 1 Non-recurring items is defined as gain on disposal of share of JV company transaction and disposal of sublease 2
situation in those targeted countries. Figure 2 EGCO’s equity contracted capacity of electricity in 2018 classified by country 1.3 Competition Overall picture in 2018 illustrated the active movements of power
3.15 26% Core EBITDA/t (US$/t)) 111 122 90 23% 110 89 24% Net Operating Debt to Equity 0.54 0.57 0.88 (39)% 0.54 0.88 (39)% Note: (1) Consolidated financials are based upon elimination of intra-company
(GLAND has 15% ownership stake in GLANDRT) by complete assets transferred of The Ninth Towers Grand Rama 9 and Unilever House Grand Rama 9 to CPNREIT. The Company has recognized the transaction in
corresponding period of the previous year, mostly from revenue from Big Lot of Trading which was a non-regular transaction decreased Baht 854.14 million, together with the decrease of regular transactions of
% The Philippines 17% Lao PDR 8% Indonesia 4% Australia 2% Thailand The Philippines Lao PDR Indonesia Australia Figure 3 EGCO’s equity contracted capacity of electricity in 2017 classified by country The